Medical Advocates
Ethics and Infectious Diseases
  Ethical Challenges
Screening/Testing
 Refusal of Care/Services
Detention
Patient Exploitation
Compulsory Treatment
Decision-Making
Reproduction
Transplants
End-of-Life Care
Enteral Nutrition
Professional Associations
National Challenges         Sterilization
Bioterrorism                     Prison Challenges
 HIV Exceptionalism           Conflicts of Interest
Pharmaceutical Industry   Pregnancy
HIV Prevention   
Stigma
 Physician Reimbursement 
Ethics and Disease Challenges and Duties
 HIV Cure
 Ebola Virus Disease
 Executions






 
Ethics Main Page Main New and Noteworthy Home Page

Medical Advocates
Abacavir/Lamivudine (Epzicom)

 
Conference Citations

XX International AIDS Conference
XIX International AIDS Conference
 6th IAS Conference
 Ninth Int Congress on Drug Therapy in HIV Infection
Archives



 
Epzicom Main Page Main New/Newsworthy   Home Page    
Last Updated:  January 26, 2015
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader\
XX International AIDS Conference
 
XIX International AIDS Conference
 
  • A WEEK-IN-REVIEW FEATURED REPORT
    POSTER
    Abacavir/lamivudine versus tenofovir/emtricitabine with either raltegravir or protease inhibitors in virologically suppressed
    patients: a sub-analysis of SPIRAL study
    E. Martinez, P. Monteiro, I. Perez, et al
    Poster     Abstract
6th IAS Conference on HIV Pathogenesis, Treatment
and Prevention
  • POSTER
         Long-term efficacy and safety of abacavir/lamivudine (ABC/3TC) and raltegravir (RAL) in antiretroviral naive HIV-1 infected subjects
    B. Young, T. Vanig, E. DeJesus, et al
    Poster     Abstract